https://xtandi-hcp.iassist.com/
Astellas Xtandi Support Solutions
astellasxtandisupportsolutions
https://www.latimes.com/business/la-fi-pfizer-medivation-acquisition-20160822-snap-story.html
Pfizer to pay $14 billion for Medivation, whose drug Xtandi was discovered by UCLA - Los Angeles...
Aug 23, 2016 - Pharmaceutical giant Pfizer Inc. is paying $14 billion to buy Medivation Inc., a San Francisco biotech company that sells a high-priced prostate cancer...
https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-xtandi-prostate-cancer-psa-recurrence
Xtandi Approved for High-Risk Prostate Cancer - NCI
Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.
high riskprostate cancerxtandiapprovednci